论文部分内容阅读
据《中华妇产科杂志》1998年1月33卷第1期报道 为了探讨晚期及复发性恶性生殖细胞肿 瘤治疗的新方法,中国医学科学院肿瘤医院洪婉君等,回顾性分析1958～1993年本院收治的129例晚期与复发性卵巢恶性生殖细胞肿瘤的治疗结果。对1984～1993年间采用VAC方案(长春新碱+更生霉素+环磷酰胺)、PVB方案(顺铂+长春新碱+博幕霉素)及BEP方案(博莱霉素十足叶乙甙+顺铂)治疗的患者生存情况与1958～1983年间采用随意治疗方案的
According to the “Chinese Journal of Obstetrics and Gynecology,” January 1998 Volume 33, No. 1 report in order to explore the treatment of advanced and recurrent malignant germ cell tumors of the new method, the Chinese Academy of Medical Sciences Hospital Hong Wanjun, retrospective analysis of the hospital from 1958 to 1993 Treatment of 129 cases of advanced and recurrent malignant ovarian germ cell tumors. From 1984 to 1993, the VAC regimen (vincristine + dactinomycin + cyclophosphamide), PVB regimen (cisplatin + vincristine + bomustine) and BEP regimen (bleomycin ethamelon + Cisplatin) treatment of patients with the survival of 1958 and 1983 random treatment program